Dennis J. Dietzen, Ph.D.

Improving existing analytic diagnostic tools and expanding the repertoire of informative biomolecules available for disease detection in children, including inborn errors of metabolism and drug exposure, as well as pre-eclampsia, intrauterine growth retardation, liver failure and neonatal hypoglycemia.